Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6407 ARTÍCULOS , VIENDO DEL 4216 AL 4230

Closed-loop brain-machine-body interfaces for noninvasive rehabilitation of movement disorders

Broccard FD, Mullen T, Chi YM, Peterson D, Iversen JR, Arnold M, Kreutz-Delgado K, Jung TP, Makeig S, Poizner H, Sejnowski T, Cauwenberghs G.

Ann Biomed Eng. 2014 Aug;42(8):1573-93. doi: 10.1007/s10439-014-1032-6. Epub 2014 May 15.

Analysis of dystonic tremor in musicians using empirical mode decomposition

Lee A, Schoonderwaldt E, Chadde M, Altenmüller E.

Clin Neurophysiol. 2015 Jan;126(1):147-53. doi: 10.1016/j.clinph.2014.04.013. Epub 2014 May 2.

When Drinking Makes the Tremor Worse: A Task-Specific Orolingual Tremor

O'Gorman CM, Bower JH, Matsumoto JY, Kantarci OH, Kumar N.

Mov Disord Clin Pract. 2014 Jun 4;1(3):237-239. doi: 10.1002/mdc3.12041. eCollection 2014 Sep.

Identification of p.Gln858* in ATP13A2 in two EOPD patients and presentation of their clinical features

Malakouti-Nejad M, Shahidi GA, Rohani M, Shojaee SM, Hashemi M, Klotzle B, Fan JB, Elahi E.

Neurosci Lett. 2014 Aug 8;577:106-11. doi: 10.1016/j.neulet.2014.06.023. Epub 2014 Jun 17.

Dystonia: an update on phenomenology, classification, pathogenesis and treatment

Balint B, Bhatia KP.

Curr Opin Neurol. 2014 Aug;27(4):468-76. doi: 10.1097/WCO.0000000000000114.

Sustained remission of Parkinson disease associated melanoma with immunotherapy

Shprecher DR, Grossmann KF, Tward JD.

Parkinsonism Relat Disord. 2014 Sep;20(9):1027-9. doi: 10.1016/j.parkreldis.2014.05.017. Epub 2014 Jun 13.

Spinal stimulation for movement disorders

Thiriez C, Gurruchaga JM, Goujon C, Fénelon G, Palfi S.

Neurotherapeutics. 2014 Jul;11(3):543-52. doi: 10.1007/s13311-014-0291-0.

[Treatment of tardive syndromes]

Horváth K, Aschermann Z, Komoly S, Kovács A, Kovács N.

Psychiatr Hung. 2014;29(2):214-24.

Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia

Tardy M, Huhn M, Engel RR, Leucht S.

Cochrane Database Syst Rev. 2014 Aug 3;2014(8):CD009230. doi: 10.1002/14651858.CD009230.pub2.

Twelve clinical pearls to help distinguish essential tremor from other tremors

Louis ED.

Expert Rev Neurother. 2014 Sep;14(9):1057-65. doi: 10.1586/14737175.2014.936389. Epub 2014 Aug 6.

Engineering the next generation of clinical deep brain stimulation technology

McIntyre CC, Chaturvedi A, Shamir RR, Lempka SF.

Brain Stimul. 2015 Jan-Feb;8(1):21-6. doi: 10.1016/j.brs.2014.07.039. Epub 2014 Jul 30.

Clinical implications of local field potentials for understanding and treating movement disorders

Thompson JA, Lanctin D, Ince NF, Abosch A.

Stereotact Funct Neurosurg. 2014;92(4):251-63. doi: 10.1159/000364913. Epub 2014 Aug 27.

Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia

Tardy M, Dold M, Engel RR, Leucht S.

Cochrane Database Syst Rev. 2014 Sep 1;2014(9):CD009227. doi: 10.1002/14651858.CD009227.pub2.

Closed loop deep brain stimulation: an evolving technology

Hosain MK, Kouzani A, Tye S.

Australas Phys Eng Sci Med. 2014 Dec;37(4):619-34. doi: 10.1007/s13246-014-0297-2. Epub 2014 Sep 7.

[Deep brain stimulation: new frontier in the treatment of CNS disorders]

Gonçalves Ferreira A.

Acta Med Port. 2014 Sep-Oct;27(5):641-8. Epub 2014 Oct 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias